Discovery, Millennium Pharmaceuticals, Inc., Cambridge, MA 02139, USA.
Mol Cell Proteomics. 2011 Nov;10(11):M111.009183. doi: 10.1074/mcp.M111.009183. Epub 2011 Aug 26.
Cullin-RING ubiquitin ligases (CRLs) are responsible for the ubiquitination of many cellular proteins, thereby targeting them for proteasomal degradation. In most cases the substrates of the CRLs have not been identified, although many of those that are known have cancer relevance. MLN4924, an investigational small molecule that is a potent and selective inhibitor of the Nedd8-activating enzyme (NAE), is currently being explored in Phase I clinical trials. Inhibition of Nedd8-activating enzyme by MLN4924 prevents the conjugation of cullin proteins with NEDD8, resulting in inactivation of the entire family of CRLs. We have performed stable isotope labeling with amino acids in cell culture analysis of A375 melanoma cells treated with MLN4924 to identify new CRL substrates, confidently identifying and quantitating 5122-6012 proteins per time point. Proteins such as MLX, EID1, KLF5, ORC6L, MAGEA6, MORF4L2, MRFAP1, MORF4L1, and TAX1BP1 are rapidly stabilized by MLN4924, suggesting that they are novel CRL substrates. Proteins up-regulated at later times were also identified and siRNA against their corresponding genes were used to evaluate their influence on MLN4924-induced cell death. Thirty-eight proteins were identified as being particularly important for the cytotoxicity of MLN4924. Strikingly, these proteins had roles in cell cycle, DNA damage repair, and ubiquitin transfer. Therefore, the combination of RNAi with stable isotope labeling with amino acids in cell culture provides a paradigm for understanding the mechanism of action of novel agents affecting the ubiquitin proteasome system and a path to identifying mechanistic biomarkers.
Cullin-RING 泛素连接酶(CRLs)负责许多细胞蛋白的泛素化,从而将它们靶向蛋白酶体降解。在大多数情况下,CRLs 的底物尚未确定,尽管已知的许多底物与癌症有关。MLN4924 是一种正在进行的 I 期临床试验的研究小分子,它是 Nedd8 激活酶(NAE)的有效和选择性抑制剂。MLN4924 抑制 Nedd8 激活酶可防止 Cullin 蛋白与 NEDD8 的缀合,从而使整个 CRL 家族失活。我们对用 MLN4924 处理的 A375 黑色素瘤细胞进行了稳定同位素标记与氨基酸标记的细胞培养分析,以鉴定新的 CRL 底物,每个时间点可自信地鉴定和定量 5122-6012 种蛋白质。MLX、EID1、KLF5、ORC6L、MAGEA6、MORF4L2、MRFAP1、MORF4L1 和 TAX1BP1 等蛋白质被 MLN4924 迅速稳定,表明它们是新的 CRL 底物。还鉴定了在较晚时间上调的蛋白质,并使用针对它们相应基因的 siRNA 来评估它们对 MLN4924 诱导的细胞死亡的影响。鉴定出 38 种蛋白质对 MLN4924 的细胞毒性特别重要。引人注目的是,这些蛋白质在细胞周期、DNA 损伤修复和泛素转移中发挥作用。因此,RNAi 与稳定同位素标记与氨基酸标记的细胞培养相结合,为理解影响泛素蛋白酶体系统的新型药物的作用机制提供了范例,并为鉴定机制性生物标志物提供了途径。